Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Kangyu Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of the publicly traded Apeloa Pharmaceutical. The company is a major manufacturer of active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong emphasis on anti-infective, cardiovascular, and oncology therapeutic areas. Its manufacturing facilities are highly regulated and have received certifications from the US FDA, EU GMP, and China NMPA, enabling it to serve both domestic and international markets. Kangyu is particularly well-known for its production of semi-synthetic antibiotics and various specialty chemicals. Beyond its own product line, the company provides contract development and manufacturing organization (CDMO) services to global pharmaceutical partners. As part of the Hengdian Group, it leverages extensive industrial resources to maintain a competitive edge in the global life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangyu Pharmaceutical.